GlassScriptPhysician profile
Said Sana
NPI 1811202948
$2,413.09
in general payments reported to CMS, 2019-2025
12 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.35 · 2023: $382 · 2024: $1,441 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628 · Travel and Lodging: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,628.00 |
| Travel and Lodging | $716.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,007.15 | 2024 | Propel, Nuvent, Stealthstation S8 Platform |
| Acclarent, INC | $297.00 | 2019-2024 | Trudi Nav Cable, Acclarent Aera |
| Genzyme Corporation | $264.20 | 2024-2025 | |
| Aerin Medical INC. | $219.32 | 2019-2025 | |
| Optinose US, INC. | $214.88 | 2025 | |
| Janssen Biotech, INC. | $130.61 | 2023-2024 | Tremfya, Simponi, Stelara |
| Incyte Corporation | $81.87 | 2023 | Opzelura |
| Integra Lifesciences Corporation | $58.08 | 2025 | Acclarent Aera |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.33 | 2023-2024 | Jublia, Duobrii, Arazlo |
| Cochlear Americas | $35.75 | 2024 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Intersect Ent, INC. | $33.01 | 2019 | |
| Greer Laboratories, INC. | $23.89 | 2025 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Said Sana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.